Additionally, an Indian expert panel emphasized that apremilast is not contraindicated in patients with liver disease and can be safely administered without dose adjustments in patients with hepatic impairment (Rajagopalan et al
Secondary antibodies (AlexaFluor 594 anti-mouse 1:500 (Invitrogen, A11005) and AlexaFluor 488 anti-rabbit 1:500 (Invitrogen, A11034)) were added to blocking buffer and incubated at room temperature for 1 h
Nie X, Zhang H, Shi X, Zhao J, Chen Y, Wu F, Yang J, Li X
Physicians are often helpless
government funding, and one of his many targets is scientific research
The best evidence for weight and cardiometabolic benefit comes at the labeled maintenance doses or higher within clinical research, not at permanently microdoses